Full Breakdown
FDA Staff Conference During Government Shutdown Raises Concerns
12/16/2025, 2:11:06 AM
Overview of the Event
In mid-November 2025, 31 staff members from the U.S. Food and Drug Administration (FDA) attended a conference in Singapore organized by the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH). This trip occurred during the longest government shutdown in U.S. history, which lasted 43 days. The travel cost exceeded $250,000, averaging over $8,000 per person. The FDA's participation was approved shortly before the shutdown ended, raising questions about the agency's priorities amid significant budget cuts and staffing reductions.
Context of the FDA's Challenges
The FDA has faced considerable challenges, including an 11.5% budget cut proposed by the Trump administration, resulting in nearly 1,900 layoffs and 1,200 early retirements. The agency's leadership has also experienced instability, with former FDA chiefs expressing concerns about its handling of critical issues, such as vaccine policies. These factors have contributed to a perception of the FDA as being under pressure to maintain its operational effectiveness.
Purpose and Outcomes of the Conference
The ICH conference, held on November 18-19, aimed to unify global standards for drug development and approval. Approximately 500 attendees included regulators and pharmaceutical industry experts. During the conference, three guidelines were adopted to streamline global drug development and safety monitoring. FDA staff contributed to these guidelines, which focus on improving clinical trial protocols, ensuring timely post-approval safety reports, and establishing standards for real-world data studies.
Official Statements & Responses
The FDA defended its decision to send staff to the conference, stating that it was "mission critical" for supporting global alignment on drug development and regulatory science. Approval for the trip was granted by senior leadership, including the FDA's chief operating officer, Barclay Butler. However, critics have raised concerns about the optics of such a trip during a government shutdown. Dylan Hedtler-Gaudette, acting vice president of policy and government affairs at the Project On Government Oversight, remarked that the situation reflects poorly on the agency's priorities and could be seen as a misuse of public resources.
Criticism & Opposition
Critics argue that sending FDA staff to an overseas conference during a government shutdown is inappropriate. Hedtler-Gaudette emphasized that while the conference may have been important, it raises questions about the agency's commitment to addressing its operational challenges. He stated, "At a minimum, it's a kind of bad look and it's poor optics," suggesting that the trip could be perceived as a dereliction of duty.
Conclusion
The FDA's decision to send staff to the ICH conference in Singapore during a government shutdown has sparked debate about the agency's priorities and resource allocation. While the FDA maintains that the trip was essential for global drug development standards, critics highlight the potential negative implications of such actions during a period of significant operational strain. As the FDA navigates these challenges, the focus remains on how it will address its internal issues while fulfilling its regulatory responsibilities.
